John H. Tucker
2022
In 2022, John H. Tucker earned a total compensation of $1.6M as President and Chief Executive Officer at scPharmaceuticals, a 14% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $319,200 |
|---|---|
| Option Awards | $683,162 |
| Salary | $580,250 |
| Other | $12,752 |
| Total | $1,595,364 |
Tucker received $683.2K in option awards, accounting for 43% of the total pay in 2022.
Tucker also received $319.2K in non-equity incentive plan, $580.3K in salary and $12.8K in other compensation.
Rankings
In 2022, John H. Tucker's compensation ranked 2,125th out of 5,758 executives tracked by ExecPay. In other words, Tucker earned more than 63.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,125 out of 5,758 | 63rd |
Division Manufacturing | 1,143 out of 3,135 | 64th |
Major group Chemicals And Allied Products | 490 out of 1,421 | 66th |
Industry group Drugs | 450 out of 1,322 | 66th |
Industry Pharmaceutical Preparations | 325 out of 968 | 66th |
Source: SEC filing on April 27, 2023.
Tucker's colleagues
We found one more compensation record of an executive who worked with John H. Tucker at scPharmaceuticals in 2022.
2022
Rachael Nokes
scPharmaceuticals
Chief Financial Officer
News
scPharmaceuticals CEO John Tucker's 2022 pay slips 14% to $1.6M
April 27, 2023
scPharmaceuticals CEO John Tucker's 2021 pay rises 7% to $1.9M
April 28, 2022
scPharmaceuticals CEO John Tucker's 2020 pay jumps 40% to $1.7M
April 27, 2021
scPharmaceuticals CEO John Tucker's 2019 pay slips 17% to $1.2M
April 27, 2020
scPharmaceuticals CEO John Tucker's 2018 pay falls 25% to $1.5M
April 30, 2019